These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29222304)

  • 1. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Models of Pain in Sickle Cell Disease.
    Sagi V; Song-Naba WL; Benson BA; Joshi SS; Gupta K
    Curr Protoc Neurosci; 2018 Oct; 85(1):e54. PubMed ID: 30265442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.
    Sagi V; Argueta DA; Kiven S; Gupta K
    Complement Ther Med; 2020 Jun; 51():102394. PubMed ID: 32507420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting pain at its source in sickle cell disease.
    Gupta K; Jahagirdar O; Gupta K
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R104-R112. PubMed ID: 29590553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain and sickle cell disease.
    Aich A; Jones MK; Gupta K
    Curr Opin Hematol; 2019 May; 26(3):131-138. PubMed ID: 30893088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.
    Nur E; Biemond BJ; Otten HM; Brandjes DP; Schnog JJ;
    Am J Hematol; 2011 Jun; 86(6):484-9. PubMed ID: 21544855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Hospitalizations for Pain and Association With Altered Brain Network Connectivity in Sickle Cell Disease.
    Darbari DS; Hampson JP; Ichesco E; Kadom N; Vezina G; Evangelou I; Clauw DJ; Taylor Vi JG; Harris RE
    J Pain; 2015 Nov; 16(11):1077-86. PubMed ID: 26291276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalist management of vaso-occlusive pain crisis in patients with sickle cell disease using a pathway of care.
    Allen Liles E; Kirsch J; Gilchrist M; Adem M
    Hosp Pract (1995); 2014 Apr; 42(2):70-6. PubMed ID: 24769786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated mechanisms underlying sickle cell disease-associated pain.
    Du S; Lin C; Tao YX
    Neurosci Lett; 2019 Nov; 712():134471. PubMed ID: 31505241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thinking beyond sickling to better understand pain in sickle cell disease.
    Darbari DS; Ballas SK; Clauw DJ
    Eur J Haematol; 2014 Aug; 93(2):89-95. PubMed ID: 24735098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.
    Deux JF; Audard V; Brugières P; Habibi A; Manea EM; Guillaud-Danis C; Godeau B; Galactéros F; Stehlé T; Lang P; Grimbert P; Audureau E; Rahmouni A; Bartolucci P
    Am J Kidney Dis; 2017 Jan; 69(1):51-59. PubMed ID: 27663041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
    Zaidi AU; Glaros AK; Lee S; Wang T; Bhojwani R; Morris E; Donohue B; Paulose J; Iorga ŞR; Nellesen D
    Orphanet J Rare Dis; 2021 Nov; 16(1):460. PubMed ID: 34727959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.